Prof. Dr. Ulrich Rothbauer

Seit 2018 Bereichsleiter für PharmaBiotech am Naturwissenschaftlichen und Medizinischen Institut (NMI), Reutlingen
 
Seit 2011 Professor der pharmazeutischen Biotechnologie an der Universität Tübingen (Brückenprofessur Universität Tübingen und dem Naturwissenschaftlichen und Medizinischen Institut (NMI) in Reutlingen
 
2008 – 2011 Geschäftsführer der ChromoTek GmbH (Martinsried, Deutschland)
 
2008 – 2010 GO-Bio Nachwuchsgruppenleiter, Biozentrum, LMU München
 
2006 – 2007 Exist-Seed Projektleiter, Biozentrum, LMU München
 
2004 – 2005 Post-Doc bei Prof. Dr. Heinrich Leonhardt, Biozentrum, LMU München
 
2003 – 2004 Post-Doc bei PD Dr. Mathias Bauer, Institut für Diabetes Forschung, München Klinik Schwabing
 
1999 – 2003 Dissertation (Dr. rer. nat.; PhD) bei Prof. Dr. Dr. Walter Neupert am Adolf-Butenandt-Institut, LMU, München zum Thema "Functional characterization of a mitochondrial mediate disease: The role of DDP1 and Tim13 for mitochondrial biogenesis".
 
1998 Diplomarbeit bei Prof. Dr. Svante Pääbo am zoologischen Institut der LMU München zum Thema „In vitro processing of overlapping tRNA transcripts in human mitochondria“
 
1992 – 1998 Studium der Biologie an der Ludwig-Maximilians Universität (LMU) München

Prof. Dr. Ulrich Rothbauer

Bereichsleiter Pharma und Biotech, Gruppenleiter Rekombinante Antikörpertechnologien
Diplom-Biologe
T +49 (0)7121 51530-415
F +49 (0)7121 51530-16

Publikationen

  • Generation and characterization of the human induced pluripotent stem cell line NMIi010-A from peripheral blood mononuclear cells of a healthy 49–year old male individual
    Keller AK, Binner A, Breitmeyer R, Vogel S, Anderle N, Rothbauer U, Schenke-Layland K, Schmees C
    Stem Cell Research Volume 54, July 2021, 102427, https://doi.org/10.1016/j.scr.2021.102427
  • Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
    Becker M, Dulovic A, Junker D, Ruetalo N, PKaiser PD, Pinilla YT, Heinzel C, Haering J, Traenkle B, Wagner TR, Layer M, Mehrlaender M, Mirakaj V, Held J, Planatscher H, Schenke-Layland K, Krause G, Strengert M, Bakchoul T, Althaus K, Fendel R, Kreidenweiss A, Koeppen M, Rothbauer U, Schindler M & Schneiderhan-Marra N
    NATURE COMMUNICATIONS| (2021) 12:3109 | https://doi.org/10.1038/s41467-021-23473-6 | www.nature.com/naturecommunications11234567890():,;
  • Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
    Becker M, Strengert M, Junker D, Kaiser P, Kerrinnes T, Traenkle B, Dinter H, Häring J, Ghozzi S, Zeck A, Weise F, Peter A, Hörber S, Fink S, Ruoff F, Dulovic A, Bakchoul T, Baillot A, Lohse S, Cornberg M, Illig T, Gottlieb J, Smola S, Karch A, Berger K, Rammensee HG, Schenke-Layland K, Nelde A, Märklin M, Heitmann JS, Walz JS, Templin M, Joos TO, Rothbauer U, Krause K & Schneiderhan-Marra N
    NATURE COMMUNICATIONS | (2021) 12:1152 | https://doi.org/10.1038/s41467-021-20973-3 | www.nature.com/naturecommunications
  • A novel epitope tagging system to visualize and monitor antigens in live cells with chromobodies
    Traenkle B, Segan S, Funmilayo F , Kaiser P, Rothbauer U
    Scientific Reports, 10, (2020) 10:14267, https://doi.org/10.1038/s41598-020-71091-x
  • Systematic Investigation of Polyurethane Biomaterial Surface Roughness on Human Immune Responses in vitro
    Segan S, Jakobi M, Khokhani P, Klimosch S, Billing F, Schneider M, Martin D, Metzger U, Biesemeier A, Xiong X, Mukherjee A, Steuer H, Keller B-M, Joos T, Schmolz M, Rothbauer U, Hartmann H, Burkhardt C, Lorenz G ,Schneiderhan-Marra N, and Shipp C
    BioMed Research International, 2020, https://doi.org/10.1155/2020/3481549
  • A Strategy to Optimize the Generation of Stable Chromobody Cell Lines for Visualization and Quantification of Endogenous Proteins in Living Cells
    Keller B, Maier J, Weldle M, Segan S, Traenkle B, Rothbauer U
    Antibodies 2019, 8, 10; doi:10.3390/antib8010010
  • Chromobodies to quantify changes of endogenous protein concentration in living cells
    Keller BM, Maier J, Secker KA, Egetemaier SM, Parfyonova Y, Rothbauer U, Traenkle B
    Mol Cell Proteomics. 2018 Dec;17(12):2517-2533. doi: 10.1074/mcp.TIR118.000914. Epub 2018 Sep 18.
  • Speed up to find the right ones: rapid discovery of functional nanobodies
    Rothbauer U
    Nat Struct Mol Biol. 2018 Mar;25(3):199-201.
  • A peptide tag-specific nanobody enables high-quality labeling for dSTORM imaging
    Virant D, Traenkle B, Maier J, Kaiser PD, Bodenhöfer M, Schmees C, Vojnovic I, Pisak-Lukáts B, Endesfelder U, Rothbauer U
    Nature Communications. 2018 Mar;9:930. DOI:10.1038/s41467-018-03191-2
  • Akt1 and Akt3 but not Akt2 through interaction with DNA-PKcs stimulate proliferation and post-irradiation cell survival of K-RAS-mutated cancer cells
    Toulany M, Maier J, Iida M, Rebholz S, Holler M, Grottke A, Jüker M, Wheeler DL, Rothbauer U, Rodemann HP
    Cell Death Discovery. 2017; 3:17072
  • Under the Microscope: Single-Domain Antibodies for Live-Cell Imaging and Super-Resolution Microscopy
    Traenkle B, Rothbauer U
    Front Immunol. 2017 Aug 24;8:1030. doi: 10.3389/fimmu.2017.01030. eCollection 2017.
  • A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib
    Sinnberg T, Makino E, Krueger MA, Velic A, Macek B, Rothbauer U, Groll N, Potz O, Czemmel S, Niessner H, Meier F, Ikenberg K, Garbe C, Schittek B
    EBioMedicine. 2016 Jun;8:132-49. doi: 10.1016/j.ebiom.2016.04.037. Epub 2016 May 1.
  • Role of BCL9L in transforming growth factor-beta (TGF-beta)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer
    Sannino G, Armbruster N, Bodenhofer M, Haerle U, Behrens D, Buchholz M, Rothbauer U, Sipos B, Schmees C
    Oncotarget. 2016 Oct 4; 7:73725-73738. doi: 10.18632/oncotarget.12455.
  • Nanobody Platform for Determination of Protein Structure, Application of Peptides and Proteins
    Traenkle B, Kaiser PD, Rothbauer U
    2016. in: Encyclopedia of Analytical Chemistry, John Wiley & Sons, Ltd, 2006.
  • From Enzyme to Whole Blood: Sequential Screening Procedure for Identification and Evaluation of p38 MAPK Inhibitors
    Bauer SM, Kubiak JM, Rothbauer U, Laufer S
    Methods Mol Biol. 2016;1360:123-48. doi: 10.1007/978-1-4939-3073-9_10.
  • A Multiplexed High-Content Screening Approach Using the Chromobody Technology to Identify Cell Cycle Modulators in Living Cells
    Schorpp K, Rothenaigner I, Maier J, Traenkle B, Rothbauer U, Hadian K
    J Biomol Screen. 2016 Oct;21(9):965-77. doi: 10.1177/1087057116641935. Epub 2016 Apr 4.
  • A New Nanobody-Based Biosensor to Study Endogenous PARP1 In Vitro and in Live Human Cells
    Buchfellner A, Yurlova L, Nuske S, Scholz AM, Bogner J, Ruf B, Zolghadr K, Drexler SE, Drexler GA., Girst S, Greubel C, Reindl J, Siebenwirth C, Romer T, Friedl AA, Rothbauer U
    PLoS One. 2016 Mar 7;11(3):e0151041. doi: 10.1371/journal.pone.0151041. eCollection 2016.
  • Peptides in headlock - a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy
    Braun MB, Traenkle B, Koch PA, Emele F, Weiss F, Poetz O, Stehle T, Rothbauer U
    Sci Rep. 2016 Jan 21;6:19211. doi: 10.1038/srep19211.
  • Real-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodies
    Maier J, Traenkle B, Rothbauer U
    Sci Rep. 2015 Aug 21;5:13402. doi: 10.1038/srep13402.
  • Live imaging of endogenous protein dynamics in zebrafish using chromobodies.
    Panza P, Maier J, Schmees C, Rothbauer U, Söllner C.
    Development. 2015 May 15;142(10):1879-84. doi: 10.1242/dev.118943.
  • Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells
    Traenkle B, Emele F, Anton R, Poetz O, Haeussler RS, Maier J, Kaiser PD, Scholz AM, Nueske S, Buchfellner A, Romer T, Rothbauer U
    Mol Cell Proteomics. 2015 Mar;14(3):707-23. doi: 10.1074/mcp.M114.044016. Epub 2015 Jan 16.
  • Generation of an alpaca-derived nanobody recognizing gamma-H2AX
    Rajan M, Mortusewicz O, Rothbauer U, Hastert FD, Schmidthals K, Rapp A, Leonhardt H, Cardoso MC
    FEBS Open Bio. 2015 Sep 21;5:779-88. doi: 10.1016/j.fob.2015.09.005. eCollection 2015.
  • Towards multiplexed protein-protein interaction analysis using protein tag-specific nanobodies
    Groll N, Emele F, Poetz O, Rothbauer U
    J Proteomics. 2015 Sep 8;127(Pt B):289-99. doi: 10.1016/j.jprot.2015.04.017. Epub 2015 May 1.
  • A p38 substrate-specific MK2-EGFP translocation assay for identification and validation of new p38 inhibitors in living cells: a comprising alternative for acquisition of cellular p38 inhibition data
    Anton R, Bauer SM, Keck PR, Laufer S, Rothbauer U
    PLoS One. 2014 Apr 17;9(4):e95641. doi: 10.1371/journal.pone.0095641. eCollection 2014.
  • Recent progress in generating intracellular functional antibody fragments to target and trace cellular components in living cells
    Kaiser PD, Maier J, Traenkle B, Emele F, Rothbauer U
    Biochim Biophys Acta. 2014 Nov;1844(11):1933-1942. doi: 10.1016/j.bbapap.2014.04.019. Epub 2014 May 2.
  • c-Jun/c-Fos heterodimers regulate cellular genes via a newly identified class of methylated DNA sequence motifs
    Gustems M, Woellmer A, Rothbauer U, Eck SH, Wieland T, Lutter D, Hammerschmidt W
    Nucleic Acids Res. 2014 Mar;42(5):3059-72. doi: 10.1093/nar/gkt1323. Epub 2013 Dec 25.
  • The Fluorescent Two-Hybrid Assay to Screen for Protein-Protein Interaction Inhibitors in Live Cells: Targeting the Interaction of p53 with Mdm2 and Mdm4
    Yurlova L, Derks M, Buchfellner A, Hickson I, Janssen M, Morrison D, Stansfield I, Brown CJ, Ghadessy FJ, Lane DP, Rothbauer U, Zolghadr K, Krausz E
    J Biomol Screen. 2014 Apr;19(4):516-25. doi: 10.1177/1087057113518067. Epub 2014 Jan 29.
  • A versatile assay for RNA-binding proteins in living cells
    Strein C, Alleaume AM, Rothbauer U, Hentze MW, Castello A
    RNA. 2014 May;20(5):721-31. doi: 10.1261/rna.043562.113. Epub 2014 Mar 24.
  • Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
    Becker M, Dulovic A, Junker D, Ruetalo N, PKaiser PD, Pinilla YT, Heinzel C, Haering J, Traenkle B, Wagner TR, Layer M, Mehrlaender M, Mirakaj V, Held J, Planatscher H, Schenke-Layland K, Krause G, Strengert M, Bakchoul T, Althaus K, Fendel R, Kreidenweiss A, Koeppen M, Rothbauer U, Schindler M & Schneiderhan-Marra N
    NATURE COMMUNICATIONS| (2021) 12:3109 | https://doi.org/10.1038/s41467-021-23473-6 | www.nature.com/naturecommunications11234567890():,;